Kancera AB (publ) (KAN) - Cash Flow Conversion Efficiency

Latest as of June 2025: -0.227x

Based on the latest financial reports, Kancera AB (publ) (KAN) has a cash flow conversion efficiency ratio of -0.227x as of June 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (Skr-9.80 Million ≈ $-1.05 Million USD) by net assets (Skr43.12 Million ≈ $4.64 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. Also see KAN market cap for the company's overall valuation and market capitalisation.

Kancera AB (publ) - Cash Flow Conversion Efficiency Trend (2010–2024)

This chart illustrates how Kancera AB (publ)'s cash flow conversion efficiency has evolved over time, based on yearly financial data.

Kancera AB (publ) Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Kancera AB (publ) ranked by their cash flow conversion efficiency. Explore KAN operating cash flow to net income to measure how well operating cash flow supports reported net income.

Company	Cash Flow Conversion Efficiency
GoldOn Resources Ltd V:GLD	-0.098x
GRUPUL INDUSTRIAL ELECTROCONTACT S.A. RO:ECT	N/A
UTime Limited NASDAQ:WTO	0.019x
Amatheon Agri Holding NV PA:MLAAH	-0.204x
Supreme PLC LSE:SUP	0.044x
Asiamet Resources Ltd F:0FK	-4.045x
EF EnergyFunders Ventures Inc V:EFV	0.007x
Fitell Corporation Ordinary Shares NASDAQ:FTEL	-0.030x

Annual Cash Flow Conversion Efficiency for Kancera AB (publ) (2010–2024)

The table below shows the annual cash flow conversion efficiency of Kancera AB (publ) from 2010 to 2024. View Kancera AB (publ) (KAN) share price today for real-time trading data and today's change.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2024-12-31	Skr62.30 Million ≈ $6.70 Million	Skr-58.53 Million ≈ $-6.30 Million	-0.940x	+19.56%
2023-12-31	Skr47.66 Million ≈ $5.13 Million	Skr-55.67 Million ≈ $-5.99 Million	-1.168x	-162.54%
2022-12-31	Skr106.91 Million ≈ $11.51 Million	Skr-47.56 Million ≈ $-5.12 Million	-0.445x	-23.54%
2021-12-31	Skr122.54 Million ≈ $13.19 Million	Skr-44.12 Million ≈ $-4.75 Million	-0.360x	+43.47%
2020-12-31	Skr72.28 Million ≈ $7.78 Million	Skr-46.05 Million ≈ $-4.96 Million	-0.637x	+66.66%
2019-12-31	Skr17.42 Million ≈ $1.87 Million	Skr-33.29 Million ≈ $-3.58 Million	-1.911x	-41.51%
2018-12-31	Skr33.36 Million ≈ $3.59 Million	Skr-45.04 Million ≈ $-4.85 Million	-1.350x	+2.37%
2017-12-31	Skr38.71 Million ≈ $4.17 Million	Skr-53.54 Million ≈ $-5.76 Million	-1.383x	-256.36%
2016-12-31	Skr59.52 Million ≈ $6.41 Million	Skr-23.10 Million ≈ $-2.49 Million	-0.388x	+58.81%
2015-12-31	Skr21.93 Million ≈ $2.36 Million	Skr-20.66 Million ≈ $-2.22 Million	-0.942x	-34.58%
2014-12-31	Skr27.29 Million ≈ $2.94 Million	Skr-19.11 Million ≈ $-2.06 Million	-0.700x	-99.93%
2013-12-31	Skr18.96 Million ≈ $2.04 Million	Skr-6.64 Million ≈ $-714.35K	-0.350x	+92.89%
2012-12-31	Skr5.50 Million ≈ $591.78K	Skr-27.08 Million ≈ $-2.91 Million	-4.925x	-449.52%
2011-12-31	Skr25.90 Million ≈ $2.79 Million	Skr-23.21 Million ≈ $-2.50 Million	-0.896x	-75.76%
2010-12-31	Skr11.07 Million ≈ $1.19 Million	Skr-5.64 Million ≈ $-607.38K	-0.510x	--

About Kancera AB (publ)

ST:KAN Sweden Biotechnology

Market Cap

$1.98 Million

Skr18.44 Million SEK

Market Cap Rank

#30110 Global

#682 in Sweden

Share Price

Skr0.15

Change (1 day)

-23.82%

52-Week Range

Skr0.15 - Skr0.31

All Time High

Skr38.15